−0.24 USD
−7.31 M USD
0.00 USD
10.11 M
About Estrella Immunopharma, Inc.
Sector
Industry
CEO
Cheng Liu
Website
Headquarters
Emeryville
Founded
2022
FIGI
BBG00ZDR7G05
Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies for patients with cancers and autoimmune diseases. The company was founded on March 30, 2022 and is headquartered in Emeryville, CA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ESLA is 1.04 USD — it has increased by 2.97% in the past 24 hours. Watch Estrella Immunopharma, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Estrella Immunopharma, Inc. stocks are traded under the ticker ESLA.
ESLA stock has risen by 20.93% compared to the previous week, the month change is a 10.64% rise, over the last year Estrella Immunopharma, Inc. has showed a −25.18% decrease.
ESLA reached its all-time high on Sep 1, 2023 with the price of 33.00 USD, and its all-time low was 0.63 USD and was reached on Oct 31, 2024. View more price dynamics on ESLA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ESLA stock is 9.00% volatile and has beta coefficient of 0.78. Track Estrella Immunopharma, Inc. stock price on the chart and check out the list of the most volatile stocks — is Estrella Immunopharma, Inc. there?
Yes, you can track Estrella Immunopharma, Inc. financials in yearly and quarterly reports right on TradingView.
ESLA net income for the last quarter is −3.38 M USD, while the quarter before that showed −3.95 M USD of net income which accounts for 14.54% change. Track more Estrella Immunopharma, Inc. financial stats to get the full picture.
No, ESLA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ESLA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Estrella Immunopharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Estrella Immunopharma, Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Estrella Immunopharma, Inc. stock shows the sell signal. See more of Estrella Immunopharma, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.